Diet for Hypoglycemia

Home > Hypoglycemia Information > Hypoglycemia News

Hypoglycemia News

  • Adding Noninsulin Antidiabetic Drugs to Metformin Therapy for Type 2 Diabetes [Letters] Tuesday, July 27, 2010 @ 3:47PMTo the Editor: The clinical review by Dr Phung and colleagues 1 showed that the different classes of noninsulin antidiabetic drugs added to metformin therapy in type 2 diabetes provided similar reduction in hemoglobin A 1c (HbA 1c ) compared with placebo.
  • Adding Noninsulin Antidiabetic Drugs to Metformin Therapy for Type 2 Diabetes [Letters] Tuesday, July 27, 2010 @ 3:46PMTo the Editor: Dr Phung and colleagues 1 presented a meta-analysis of the effectiveness of several classes of antidiabetic agents used in combination with metformin, examining the effects on glycemic control, body weight, and hypoglycemia.
  • New technology can give diabetics greater freedom Thursday, July 22, 2010 @ 12:59PMNo description available
  • Health Calendar Thursday, July 22, 2010 @ 4:28AMFitness
  • Health Calendar Thursday, July 22, 2010 @ 4:12AMAdventist Paulson Rehab Network , 619 Plainfield Road, Willowbrook, offers different fitness and exercise regimens including pre and post natal exercise, pool class, advanced circuit training program, keep it moving small group exercise class, arthritis foundation aquatic program, aquatic exercise classes and therapeutic massage.
  • Amylin Pharmaceuticals Reports Second Quarter Financial Results Wednesday, July 21, 2010 @ 3:05PMAmylin Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million.
  • AMRI initiates enrollment for Phase I study of ALB-127158 for obesity Wednesday, July 21, 2010 @ 8:08AMAMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also ...
  • New Publications Examine Treatment Outcomes For Infantile Hemangiomas Tuesday, July 20, 2010 @ 4:14PMNational research team seeks clues, causes, associations and improved/safer treatment optionsIn an ongoing effort to find better and safer treatment for complicated infantile hemangiomas, researchers at The Medical College of Wisconsin and Children's Hospital of Wisconsin, report outcomes on two treatment options. The first study examined the effects of oral steroids on a group of patients and ...
  • Seeking Clues, Causes, Associations And Improved/Safer Treatment Options For Infantile Hemangiomas Tuesday, July 20, 2010 @ 7:27AMIn an ongoing effort to find better and safer treatment for complicated infantile hemangiomas, researchers at The Medical College of Wisconsin and Children's Hospital of Wisconsin, report outcomes on two treatment options. The first study examined the effects of oral steroids on a group of patients and the second highlights possible complication/side effect from propranolol, a novel therapy for ...
  • BioInvent reports net revenues of SEK 63.1M for January - June 2010 period Wednesday, July 14, 2010 @ 8:08AMBioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development ...
  • EDP Announces Single Injection of New Insulin Maintains Tight Glucose Control for 140 Days Tuesday, July 13, 2010 @ 8:15AMDARIEN, Conn.----Extended Delivery Pharmaceuticals, LLC announces that data regarding its lead development candidate SIA-II Insulin will be published in the new issue of Proceedings of the National Academy of Sciences of the USA.
  • 2 hayan rason sa kuyap, pag-wild sa runner Monday, July 12, 2010 @ 10:20AMDUHA ang mga posibilidad nga hinungdan nga nawad-an sa buot kadtong runner nga nilayat sa bintana sa Mandaue City Hospital niadtong Sabado sa gabii human siya mawad-i og panimuot sa iyang pagsalmot sa Energizer Night Run. read more
  • Woman gets 10-year sentence in plea deal Wednesday, July 7, 2010 @ 2:46PMInfant injected with insulin while in baby sitter's care
  • Woman who shot baby with insulin gets 10 years Wednesday, July 7, 2010 @ 9:31AMJonathon Shacat/Wick Communications A baby sitter who injected an infant with insulin last year was sentenced to serve 10 years in prison on Wednesday in Cochise County Superior Court.
  • Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions Thursday, July 1, 2010 @ 6:23AMStudies of a more-rapid-acting injectable human insulin formulation (VIAject®) in the treatment of type 1 and type 2 diabetes and of a novel insulin analog formulation (Vialog™) in an animal model of diabetes were reported this week in three poster presentations at the 70th Scientific Sessions of the American Diabetes Association in Orlando, Florida. The findings are based upon results from ...
  • Health Calendar Thursday, July 1, 2010 @ 4:38AMFitness
  • Health Calendar Thursday, July 1, 2010 @ 4:10AMAdventist Paulson Rehab Network , 619 Plainfield Road, Willowbrook, offers different fitness and exercise regimens including pre and post natal exercise, pool class, advanced circuit training program, keep it moving small group exercise class, arthritis foundation aquatic program, aquatic exercise classes and therapeutic massage.
  • Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp Wednesday, June 30, 2010 @ 7:16PMORLANDO, Fla., June 30 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and Indy Lights race car driver Charlie Kimball today announced the availability of a wide array of resources to help kids with diabetes have a positive and rewarding summer camp experience. Kimball, who has type 1 diabetes, will hand out one of these resources today to attendees at the Children with Diabetes ...
  • Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes Wednesday, June 30, 2010 @ 4:57PMBackground Recently developed technologies for the treatment of type 1 diabetes mellitus include a variety of pumps and pumps with glucose sensors. Methods In this 1-year, multicenter, randomized, controlled trial, ...
  • One injection a week for diabetes patients? Wednesday, June 30, 2010 @ 4:57PMLong-suffering diabetics can find daily insulin jabs painful and cumbersome, so a new, once-a-week shot may soon revolutionize treatment for thousands suffering from the dreaded disease.
  • Sensor and insulin pump combo could control blood sugar in diabetics Wednesday, June 30, 2010 @ 3:59AMWashington, June 30 : Using sensors and insulin pump instead of multiple daily insulin injections could bring down average blood sugar levels in diabetics, according to a study.
  • Marcadia, Lilly sign deal on hypoglycemia drug Tuesday, June 29, 2010 @ 9:33PMMarcadia Biotech of Carmel said Monday it has signed a licensing agreement with Indianapolis-based Eli Lilly and Co. to commercialize a short-acting glucagon that is designed to treat extreme low blood sugar, known as hypoglycemia.
  • Allison accelerates hybrid manufacturing Monday, June 28, 2010 @ 5:25PMAllison Transmission Inc. says it is investing more than $130million to make drive systems for commercial hybrid trucks at afacility that will employ nearly 100 workers. The company says itis gutting a dormant Indianapolis plant and transforming it into ahigh-tech facility capable of producing 20,000 propulsion systemsfor hybrid vehicles with pick up and delivery, shuttle and utilityapplications ...
  • Artificial Pancreas Could Be Available In A Few Years Monday, June 28, 2010 @ 3:17PMResearchers speaking at an annual conference suggested that research into making an artificial pancreas so patients with type 1 diabetes can better control glucose levels, is progressing rapidly and that the technology could be commercially available in just a few years...
  • Inhaled Insulin May Help Treat Diabetes Thursday, June 24, 2010 @ 5:39PMInhaled insulin proved to be as effective at lowering blood sugar levels as insulin injections, and with minimal side effects, among patients with uncontrolled type 2 diabetes, according to a new study.
  • American Diabetes Association/The Lancet Symposium Will Highlight Study Showing AFREZZA Provides Comparable Glycemic ... Thursday, June 24, 2010 @ 5:30PMORLANDO, Fla.----AFREZZATM Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, combined with basal insulin is comparable to standard insulin therapy in controlling post-meal blood sugar levels in adult patients with Type 2 diabetes, and offers the added benefits of significantly less weight gain and lower risk of hypoglycemia.
  • Breast Milk Transmits Drugs And Medicines Thursday, June 24, 2010 @ 12:13PMNicotine, caffeine and alcoholThe breast milk of smoking mothers contains between 2 and 240 nanograms of nicotine per milliliter, which means their babies receive a dose equivalent to 0.3 to 36 micrograms/kg/day. These infants tend to suffer more from colic and are more prone to respiratory infections.The advice is to give up smoking during pregnancy and breastfeeding, or at least to limit the ...
  • Tenn. police: No foul play in car deaths Tuesday, June 22, 2010 @ 4:12PMNASHVILLE, June 22 (UPI) -- Authorities say they've found no evidence of foul play in the death of two Nashville residents found dead in their car in a Wal-Mart parking lot.
  • Deborah Schoeberlein: Hypoglycemia: Be Aware or Beware! Tuesday, June 22, 2010 @ 11:14AMHere are some ideas about what to do when dealing with a normally rational individual who becomes utterly irrational when running on empty.
  • Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' To Treat Diabetes And Obesity Enters Phase I Clinical Trial Tuesday, June 22, 2010 @ 7:33AMZydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule. The new class of anti-diabetic drugs called Glucagon Like Peptide-1 (GLP -1 ...
  • No foul play in deaths of two family members found in car, police say Tuesday, June 22, 2010 @ 2:20AMAuthorities say there is no evidence of foul play in the deaths of a Nashville woman and her stepfather, both of whom were reported missing last week.
  • Police: No foul play in death of missing woman, stepfather Monday, June 21, 2010 @ 5:36PMMedical examiner waiting for toxicology before releasing cause of death More
  • Cadila Gets DCGT Approval For ZYOG1 Clinical Trial Monday, June 21, 2010 @ 4:34AMShares of Cadila Healthcare soared over 3% to a fresh 52-week high on the BSE Monday after the healthcare provider said it has received phase I clinical trial permission from the Drug Controller General of India for ZYOG1, a novel, oral, anti-diabetic molecule, which represents next generation
  • Missing woman, stepfather found dead in south Nashville Monday, June 21, 2010 @ 2:36AMPolice said they found no signs of foul play More
  • Missing woman, stepfather found dead Sunday, June 20, 2010 @ 2:39PMAn examination of the bodies showed no visible trauma and foul play was not immediately apparent. Autopsies will be performed.
  • Missing Woman, Stepfather Found Dead Sunday, June 20, 2010 @ 12:39PMPolice said that foul play was not apparent so far in the deaths of a missing woman and her stepfather who were found dead nearly five days after being reported missing.
  • Deaths/Causes May 4 — June 9 Sunday, June 20, 2010 @ 12:08AMdeath records for june 20
  • Hospital notes Saturday, June 19, 2010 @ 8:01PMGrady Memorial Hospital
  • Artificial Pancreas Can Prevent The Development Of Hypoglycemia Saturday, June 19, 2010 @ 6:17AMAn article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes.(1) Moreover, the first clinical trial of an artificial pancreas system delivering both insulin and glucagon has shown that this system can prevent development of hypoglycemia.(2) The ...
  • -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces ... Thursday, June 17, 2010 @ 5:00AMNeurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. Â The companies will work jointly to identify and advance candidates into pre-clinical development. Â Boehringer Ingelheim is responsible for the global ...
  • New perspectives in type 2 diabetes, cardiovascular risk, and treatment goals Wednesday, June 16, 2010 @ 6:15PMAn article published in the May 2010 issue of Postgraduate Medicine highlights the seriousness of cardiovascular disease (CVD) in patients with type 2 diabetes. Cardiovascular disease is the cause of death in 65% of patients with diabetes, and when complicated by the presence of obesity, the lifetime risk of developing CVD increases to 90%. The inherent problem is that many of the ...
  • BIOCIUS Life Sciences, BlueSky Biotech collaborate to offer Sirtuin pre-validated assay solution Wednesday, June 16, 2010 @ 12:15AMBIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry's only Sirtuin (SIRT, silent mating type information regulation homolog) enzyme preparations fully-validated in a label-free functional assay.
  • Central Washington Hospital improves patient experience with Toshiba' Vantage Titan MR system Tuesday, June 15, 2010 @ 6:30AMIn today's demanding health care environment, many community hospitals require imaging equipment that provides a variety of advanced diagnostic exams with features that improve patient cooperation. To offer a variety of high-quality, comfortable MR exams to its patients, Central Washington Hospital in Wenatchee, Wash., selected Toshiba America Medical Systems' Vantage TitanTM MR system.
  • Programs try cash incentives to get forgetful patients to take meds Monday, June 14, 2010 @ 9:45AMThe New York Times reports on a new approach to getting patients to take their medications consistently: financial incentives. "One-third to one-half of all patients do not take medication as prescribed, and up to one-quarter never fill prescriptions at all, experts say. Such lapses fuel more than $100 billion dollars in health costs annually because those patients often get sicker. Now, a ...
  • Scary Replay: Celtic's Son Hospitalized Again Monday, June 14, 2010 @ 6:41AMTwo years later and again, just one day before the Boston Celtics play the Los Angeles Lakers in another critical Game 5, Ray Allen's youngest son was rushed to the hospital.
  • Allen makes right moves Monday, June 14, 2010 @ 2:59AMFor the third straight game, the Ray Allen who made a playoff-record eight 3-pointers in Game 2 was nowhere to be found. The second most-prolific 3-point shooter in NBA history appeared to be an afterthought. But Ray Allen the gritty veteran, the guy willing to do anything to bring his team within a game of a title, was everywhere. Ray Allen - National Basketball Association - Three-point field ...
  • Mayo Clinic researchers developing new class of drugs to treat diabetes Friday, June 11, 2010 @ 3:07PMMalcolm Leissring and his team of researchers at the Mayo Clinic in Jacksonville, Florida are partying like it’s 1955. Using work developed by scientists more than five decades ago, Leissring, an assistant professor of molecular neuroscience, has identified a way to prevent an insulin-chewing enzyme from breaking down the hormone needed to remove sugar from the [...]
  • Market Commentary and Intraday News Thursday, June 10, 2010 @ 12:29PM(AP:VALENCIA, Calif.) MannKind Corp. said Thursday a clinical trial showed its inhaled insulin Afrezza worked as well as injectable insulin as a treatment for Type 1 diabetes.
  • AFREZZA Demonstrates Non-Inferiority Compared to Standard Therapy in Controlling Blood Sugar Levels in Type 1 Diabetes ... Thursday, June 10, 2010 @ 9:30AMVALENCIA, Calif.----MannKind Corporation today announced that results of a new 16-week trial show that the investigational ultra rapid acting mealtime insulin, AFREZZA™ Inhalation Powder, combined with basal insulin, is clearly non-inferior to standard therapy insulin lispro, a rapid acting insulin, also combined with basal insulin, in reducing HbA1c levels in subjects with inadequately ...
  • Drinking coffee may help prevent diabetes, report scientists Thursday, June 10, 2010 @ 12:56AMScientists are reporting new evidence that drinking coffee may help prevent diabetes and that caffeine may be the ingredient largely responsible for this effect. Their findings, among the first animal studies to demonstrate this apparent link, appear in ACS' bi-weekly Journal of Agricultural and Food Chemistry.